Mechanisms of occupational asthma

Clinical and Experimental Allergy, Supplement

Volumn 27, Issue 1, 1997, Pages 47-54

  Maestrelli, P ^a   Saetta, M ^a   Mapp, C ^a   Fabbri, L M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOPATHOGENESIS; LUNG LAVAGE; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ANIMALS; ASTHMA; OCCUPATIONAL DISEASES;

EID: 0030967593     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (83)

1. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995; 333:107-12.
2. Burrows B, Martinez FD, Halonen M et al. Association of asthma with serum IgE levels and skin-tests reactivity to allergens. N Engl J Med 1989; 320:271-7.
3. Sporik R, Holgate ST, Platts-Mills TAE, Cogsewell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med 1990; 323:502-7.
4. Sheffer AL. Global strategy for asthma management and prevention. NIHLBI/WHO Workshop Report, Publication 95-3659. National Institute of Health, 1995.
5. Saetta M, Di Stefano A, Maestrelli P et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992; 145:160-8.
6. Frew AJ, Chan H, Lam S, Chang-Yeung M. Bronchial inflammation asthma due to western red cedar. Am J Respir Crit Care Med 1995; 151:340-4.
7. Boulet LP, Boutet M, Laviolette M et al. Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents. Eur Respir J 1994; 7:1567-75.
8. Holt PG. Regulation of T-cell responses to inhalant allergens. Allergy Clin Immunol News 1991; 3/5:154-6.
9. Harding CV. Cellular and molecular aspects of antigen processing and the function of class II MHC molecules. Am J Respir Cell Mol Biol 1993; 8:461-7.
10. Holgate ST. Cells, cytokines and inflammation in asthma. Postgraduate syllabus and asthma consultant's course. New York: AAAAI 1995; 1-40.
11. Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995; 15:121-9
12. Maestrelli P, O'Heir RE, Tsai JJ et al. Antigen-induced neutrophil chemotactic factor derived from cloned human T lymphocytes. Immunology 1988; 65:605-9.
13. Kita O, Weiler D, Sur S et al. Il-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147:901-7.
14. + cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J All Clin Immunol 1993; 92:313-24.
15. + T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis 1990; 141:970-77.
16. Robinson DS, Hamid Q, Sun Ying, Bentley AM et al. Prednisone treatment in bronchial asthma. Clinical improvement is accompanied by reduction in bronchoalveolar lavage eosinophilia and modulation of IL-4, IL-5 and IFN-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148:401-6.
17. Corrigan CJ, Haczku A, Gemou-Engesaeth V et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentration of interleukin-5. Effect of glucorticoid therapy. Am Rev Respir Dis 1993; 147:540-7.
18. Bradding P, Feather IH, Howarth PH et al. Interleukin-4 is localised to and released by human mast cells. J Exp Med 1992; 176:1381-6.
19. Kay AB, Corrigan CJ, Frew AJ. The role of cellular immunology in asthma. Eur Respir J 1991; 4 (Suppl. 3):105-22.
20. Zangrilli JG, Peters SP. Cytokines in allergic airways diseases. In: Busse WW, Holgate ST eds. Asthma and rhinitis. Boston: Blackwell Scientific Publications, 1995;426-36.
21. Azzawi M, Bradley B, Jeffery PK et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407-13.
22. Bradley BL, Azzawi M, Jacobson M et al. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88:661-74.
23. Bentley AM, Menz G, Storz Chr et al. Identification of T-lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992; 146:500-6.
24. Bentley AM, Maestrelli P, Saetta M et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992; 89:821-9.
25. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. Saunders Co., 1995.
26. +, MHC class I-restricted T cell clones that down-regulate in vitro antibody synthesis. J Immunol 1991; 147:3370-80.
27. Kalish RS, Morimoto C. Urushiol (poison ivy) triggered suppression T cell clone generated from peripheral blood. J Clin Invest 1988; 82:825-32.
28. Wenzel SE. Asthma as an inflammatory disease. Sem Respir Med 1994; 15:106-16.
29. Rasanen L, Kuusisto P, Penttila M, Nieminen M, et al. Comparison of immunologic tests in the diagnosis of occupational asthma and rhinitis. Allergy 1994; 49:342-7.
30. Maccia CA, Bernstein IL, Emmett EA, Brooks SM. In vitro demonstration of specific IgE in phthalic anhydride hypersensitivity. Am Rev Respir Dis 1976; 113:701-4.
31. Biagini RE, Bernstein IL, Gallagher JS et al. The diversity of reaginic immune responses to platinum and palladium metallic salts. J Allergy Clin Immunol 1985; 76:794-802.
32. Cartier A, Grammer L, Malo JL et al. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 1989; 8:507-14.
33. Chan-Yeung M. Mechanism of occupational asthma due to western red cedar (Thuja plicata). Am J Ind Med 1994; 25:13-8.
34. Herd ZL, Bernstein DI. Antigen-specific stimulation of histamine releasing factors in diisocyanate-induced occupational asthma. Am J Respir Crit Care Med 1994; 150:988-94.
35. Maestrelli P, Baur X, Bessot JC et al. Guidelines for the diagnosis of occupational asthma. Clin Exp Allergy 1992; 22:103-8.
36. Biagini RE, Klincewicz SL, Henninsen GM et al. Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci 1990; 47:897-908.
37. Hamid Q, Azzawi M, Ying S et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87:1541-6.
38. Finotto S, Fabbri LM, Rado V, Mapp CE, Maestrelli P. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br J Ind Med 1991; 48:116-21.
39. Herzog CH, Villiger B, Braun P. Nickel-specific T cell clones in asthma: preferential use of V-beta 14 in T cell receptor beta chain. Eur Respir Rev 1991; 4:425s.
40. Kusaka Y, Nakano Y, Shirakawa T, Morimoto K. Lymphocyte transformation with cobalt in hard metal asthma. Ind Health 1989; 27:155-63.
41. Maestrelli P, Del Prete GF, De Carli M et al. CD-8 T-cells producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene-diisocyanate. Scand J Work Environ Health 1994; 20:376-81.
42. Del Prete GF, De Carli M, Maestrelli P et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23:1445-9.
43. Walker C, Bode E, Boer L et al Allergic and intrinsic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and BAL. Am Rev Respir Dis 1992; 148:109-15.
44. Semenzato GP. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis, and HIV infections. Eur Respir J 1991; 4:95-102.
45. Saltini C, Vinestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989; 320:1103-9.
46. Shelhamer JH. Airway inflammation. Ann Intern Med 1995; 123:288-3044.
47. O' Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987; 136:740-51.
48. Drazen JM, Turino G. Progress at the interface of inflammation and asthma. Workshop report. Am J Respir Crit Care Med 1995; 152:385-424.
49. Fabbri LM, Ciaccia A. Investigative bronchoscopy in asthma and other airways diseases. Eur Respir J 1992; 5:8-11.
50. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg J, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-9.
51. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents in induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93:1031-9.
52. Chan-Yeung M, Leriche J, McLean L, Lam S. Comparison of cellular and protein changes in bronchial lavage fluid of symptomatic and asymptomatic patients with red cedar asthma on follow-up examination. Clin Allergy 1988; 18:359-65.
53. Paggiaro PL, Paoletti P, Bacci E et al. Eosinophils in bronchoalveolar lavage (BAL) of patients with toluene diisocyanate (TDI) asthma after cessation of work. Chest 1990; 98:536-42.
54. Fabbri LM, Boschetto P, Zocca E et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate (TDI). Am Rev Respir Dis 1987;136:36-42.
55. Lam S, LeRiche J, Phillips D, Chan-Yeung M. Cellular and protein changes in bronchoalveolar lavage fluid after late asthmatic reactions in patients with red cedar asthma. J Allergy Clin Immunol 1987; 80:44-50.
56. De Monchy GR, Kauffman HF, Venge P et al. Bronchoalveolar eosinophilia following allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
57. Fabbri LM, DeRose V, Godard PH, Boschetto P, Rossi GA. Guidelines for bronchoalveolar lavage in asthma. Eur Respir Rev 1992; 2:116-23.
58. Kleck K, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989; 2:561-85.
59. Workshop summary and guidelines. Investigative use of bronchoscopy, lavage and biopsies in asthma and other airway diseases. Eur Respir J 1991; 5:115-21.
60. Chan-Yeung M, Chan H, Tse KS, Salari H, Lam S. Histamine and leukotrienes release in bronchoalveolar lavage fluid during plicatic acid induced bronchoconstriction. J Allergy Clin Immunol 1989; 84:762-8.
61. Zocca E, Fabbri LM, Boschetto P et al. Leukotriene B4 and late asthmatic reactions induced by toluene diisocyanate. J Appl Physiol 1990; 68:1576-89.
62. Persson CGA, Andersson M, Greiff L et al. Airway permeability. Clin Exp Allergy 1995; 25:807.
63. Persson CGA, Greiff L, Andersson M et al. Mucosal exudation of plasma in asthma and rhinitis. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Boston: Blackwell Scientific Publications, 1995;733-41.
64. Fabbri LM, Danieli D, Crescioli S et al. Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 1988; 137:1494-98.
65. Ehrlich RI. Fatal asthma in a baker: a case report. Am J Ind Med 1994; 26:799-802.
66. Maestrelli P, Di Stefano A, Occari P et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med 1995; 151:607-12.
67. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606.
68. Saetta M, Fabbri LM, Danieli D, Picotti G, Allegra L. Pathology of bronchial asthma and animal models of asthma. Eur Respir J 1989; 2(suppl 6):477-82.
69. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
70. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.
71. Saetta M, Maestrelli P, Di Stefano A et al. Effect of cessation of exposure to toluene diisocyanate (TDI) in bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992; 145:169-74.
72. Saetta M, Maestrelli P, Mapp CE, et al. Airway remodeling in isocyanate induced asthma. Am J Respir Crit Care Med 1995; 151:489-94.
73. Di Stefano A, Saetta M, Maestrelli P et al. Mast cells in airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1993; 147:1005-9.
74. Maestrelli P, Saetta M, Di Stefano A, Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri LM. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995; 152:1926-31.
75. Maestrelli P, Calcagni PG, Saetta M, Di Stefano A, Hosselet J-J, Santonastaso A, Fabbri LM, Mapp CE. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy 1994; 24:29-34.
76. Holgate ST. Recent advances in the genetics of asthma and allergy. Clin Exp Allergy 1995; 25: Suppl 2.
77. Howell WM, Holgate ST. HLA genetics and allergic disease. Thorax 1995; 50:815-8.
78. Marsh DG, Holgate SJ, Lochkart A. The genetics of asthma. Oxford: Blackwell Scientific Publications, 1993.
79. Bignon JS, Ju Li-Ya, Aron Yolande et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 1994; 149:71-5.
80. Balboni A, Baricordi OR, Fabbri LM et al. Association between toluene diisocyanate induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J 1996; 9:207-10.
81. Sasazuki T. HLA linked immune suppression genes. Jpn J Human Genet 1990; 35:1-13.
82. Marsh DG. Immunogenetic and immunochemical factors determining immune responsiveness to allergens: studies in unrelated subjects. In: DG Marsh, Blumenthal MN eds. Genetic and environmental factors in clinical allergy. Minneapolis: University of Minnesota Press, 1990; 97:123.
83. Reid MJ, Nish WA, Wishman BA et al. HLA DR4-associated nonresponsiveness in mountain-cedar allergen. J Allergy Clin Immunol 1992; 89:593-98.